2013 American Transplant Congress
Vancomycin-Resistant Enterococcus (VRE) Surgical Infection Following Liver Transplant (LT)
University of Pittsburgh, Pittsburgh
Background: VRE infection occurs in about 10% of LT patients (pts) and is associated with increased length of hospital stay and decreased survival. Some risk…2013 American Transplant Congress
Plasma Osteopontin Levels Correlate with Reversible Kidney Injury in Liver Transplant Candidates
Background: Predicting post-liver transplant (LT) recovery of renal dysfunction (RD) remains a significant clinical challenge. Biomarkers predictive of recovery would be helpful in the management…2013 American Transplant Congress
Absence of the MicroRNA miR-182 in CD4+T Cells Prolongs Allograft Survival
Department of Surgery/Division of Abdominal Transplantation, Stanford University, Stanford, CA
MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate the post-transcriptional expression of target genes and are important regulators in many biologic processes including innate…2013 American Transplant Congress
Effect of Transient BK Viremia after T-Cell Depleting Antibody Therapy in Kidney Transplant Recipients, The
Dept of Surgery, MTI, Miami; Dept of Medicine, Univ. of Miami Miller School of Medicine, Miami, FL
Polyoma BK virus-associated nephropathy (BKVN) is a significant cause of premature graft loss in kidney transplant recipients. Transient BK viremia is observed after an induction…2013 American Transplant Congress
Clinical and Mechanistic Outcomes of Photopheresis after Heart Transplantation
Cedars-Sinai Heart Institute, Los Angeles, CA
BACKGROUND: Photopheresis is a form of maintenance therapy designed to treat heart transplant patients who have had refractory rejection, chronic left ventricular dysfunction, or chronically…2013 American Transplant Congress
Graft Function and Transplant Vasculopathy after Alemtuzumab Induction in Cardiac Transplantation: Five Year Outcomes
Purpose: The long-term effects on graft function and vasculopathy with the routine use of alemtuzumab (C-1H) induction therapy and lower intensity maintenance immunosuppression in cardiac…2013 American Transplant Congress
6-Month Universal CMV Prophylaxis and Neutropenia in Kidney Transplant Patients Induced with Alemtuzumab: A Single Center Retrospective Study
Background: Cytomegalovirus remains the leading cause of infectious morbidity in transplant recipients. Universal prophylaxis of kidney transplant patients with oral valganciclovir (valGCV) has reduced the…2013 American Transplant Congress
Does Pre-Transplant TIPS Increase the Risk of Portal Hyper-Perfusion to Liver Grafts?
Introduction:Transjugular intrahepatic portosystemic shunt (TIPS) has been commonly used as a bridge to liver transplantation (LT). However, TIPS diminishes collateral veins and may increase the…2013 American Transplant Congress
Matrix Metalloproteinase-9 Deficiency Enhances Regeneration of Marginal Steatotic Livers after Ischemia and Reperfusion Injury
The Dumont-UCLA Transplant Center, Los Angeles, CA
The shortage of donor organs has led to an increased use of suboptimal steatotic livers in transplantation; however, fatty livers present high risks of dysfunction…2013 American Transplant Congress
Early Tubular Injury and Late Graft Dysfunction Associated with Cytomegalovirus Infection in Kidney Transplants
Hospital Israelita Albert Einstein, São Paulo, Brazil
INTRODUCTION: The indirect effects of CMV infection can be related with IF/TA in renal transplants. The aims of this work are to evaluate the impact…
American Transplant Congress abstracts